Life Sciences and Technology IPO and SPAC Overview Panel

Life Sciences and Technology IPO and SPAC Overview Panel

Presented on February 8, 2021

Findley Gillespie, Principal, Life Sciences Practice
Jeremy Kuhlmann, Principal, Life Sciences Practice
Amanda Rose, Corporate Partner, Fenwick

2020 was another active year in the life sciences and technology markets, despite the impacts of COVID-19. View our panel with Moss Adams Partners Jeremy Kuhlmann and Findley Gillespie and Fenwick Corporate Partner Amanda Rose, as we recap 2020, look at 2021, and discuss considerations for companies contemplating public exits via initial public offerings (IPOs) or special purpose acquisition companies (SPACs).

Related Topics

3 Internal Control Considerations for the IPO Journey of Life Science Companies

Efficiencies with Data and Internal Controls Could Translate to Revenue

Preparing for an IPO? 6 Tax Considerations for Life Sciences Companies

Want to Be Ready for a Transaction? Prepare Now with These 6 Steps

Contact Us with Questions

First Name

Last Name

Email

Organization

Title

City

State

Phone

Additional Information

How did you hear about us?

I agree to the terms and conditions of the Moss Adams privacy policy <a href="/privacy" target="_blank">here</a>.

I agree to the terms and conditions of the Moss Adams privacy policy here.

The material appearing in this communication is for informational purposes only and should not be construed as advice of any kind, including legal, accounting, tax, or investment advice. This information is not intended to create, and receipt does not constitute, a legal relationship, including, but not limited to, an accountant-client relationship. Although these materials have been prepared by professionals, the user should not substitute these materials for professional services, and should seek advice from an independent advisor before acting on any information presented. Changes in tax laws or other factors could affect the information provided in this communication. Past performance does not guarantee future performance. All investments may lose money.

Baker Tilly US, LLP, Baker Tilly Advisory Group, LP and Moss Adams LLP and their affiliated entities operate under an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable laws, regulations and professional standards. Baker Tilly Advisory Group, LP and its subsidiaries, and Baker Tilly US, LLP and its affiliated entities, trading as Baker Tilly, are members of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities. Baker Tilly US, LLP and Moss Adams LLP are licensed CPA firms that provide assurance services to their clients. Baker Tilly Advisory Group, LP and its subsidiary entities provide tax and consulting services to their clients and are not licensed CPA firms. ISO certification services offered through Moss Adams Certifications LLC. Investment advisory offered through either Moss Adams Wealth Advisors LLC or Baker Tilly Wealth Management, LLC.